338 related articles for article (PubMed ID: 25425528)
1. Should small papillary thyroid cancer be observed? A population-based study.
Nilubol N; Kebebew E
Cancer; 2015 Apr; 121(7):1017-24. PubMed ID: 25425528
[TBL] [Abstract][Full Text] [Related]
2. Can minimally invasive follicular thyroid cancer be approached as a benign lesion?: a population-level analysis of survival among 1,200 patients.
Goffredo P; Cheung K; Roman SA; Sosa JA
Ann Surg Oncol; 2013 Mar; 20(3):767-72. PubMed ID: 23111705
[TBL] [Abstract][Full Text] [Related]
3. Follicular variant of papillary thyroid carcinoma is a unique clinical entity: a population-based study of 10,740 cases.
Yu XM; Schneider DF; Leverson G; Chen H; Sippel RS
Thyroid; 2013 Oct; 23(10):1263-8. PubMed ID: 23477346
[TBL] [Abstract][Full Text] [Related]
4. Risk of recurrence in a homogeneously managed pT3-differentiated thyroid carcinoma population.
Chereau N; Dauzier E; Godiris-Petit G; Noullet S; Brocheriou I; Leenhardt L; Buffet C; Menegaux F
Langenbecks Arch Surg; 2018 May; 403(3):325-332. PubMed ID: 29445865
[TBL] [Abstract][Full Text] [Related]
5. Lymph node metastases do not impact survival in follicular variant papillary thyroid cancer.
Schneider DF; Elfenbein D; Lloyd RV; Chen H; Sippel RS
Ann Surg Oncol; 2015 Jan; 22(1):158-63. PubMed ID: 25092163
[TBL] [Abstract][Full Text] [Related]
6. Aggressive variants of papillary thyroid cancer: incidence, characteristics and predictors of survival among 43,738 patients.
Kazaure HS; Roman SA; Sosa JA
Ann Surg Oncol; 2012 Jun; 19(6):1874-80. PubMed ID: 22065195
[TBL] [Abstract][Full Text] [Related]
7. Racial disparities of differentiated thyroid carcinoma: clinical behavior, treatments, and long-term outcomes.
Tang J; Kong D; Cui Q; Wang K; Zhang D; Liao X; Gong Y; Wu G
World J Surg Oncol; 2018 Mar; 16(1):45. PubMed ID: 29506526
[TBL] [Abstract][Full Text] [Related]
8. Prognostic variables of papillary and follicular thyroid carcinoma patients with lymph node metastases and without distant metastases.
Lin JD; Liou MJ; Chao TC; Weng HF; Ho YS
Endocr Relat Cancer; 1999 Mar; 6(1):109-15. PubMed ID: 10732793
[TBL] [Abstract][Full Text] [Related]
9. The effects of surgery, radioiodine, and external radiation therapy on the clinical outcome of patients with differentiated thyroid carcinoma.
Tsang RW; Brierley JD; Simpson WJ; Panzarella T; Gospodarowicz MK; Sutcliffe SB
Cancer; 1998 Jan; 82(2):375-88. PubMed ID: 9445196
[TBL] [Abstract][Full Text] [Related]
10. Pathological tumor-node-metastasis (pTNM) staging for papillary and follicular thyroid carcinomas: a retrospective analysis of 700 patients.
Loh KC; Greenspan FS; Gee L; Miller TR; Yeo PP
J Clin Endocrinol Metab; 1997 Nov; 82(11):3553-62. PubMed ID: 9360506
[TBL] [Abstract][Full Text] [Related]
11. Soft tissue invasion of papillary thyroid carcinoma.
Lin JD; Hsueh C; Chao TC
Clin Exp Metastasis; 2016 Aug; 33(6):601-8. PubMed ID: 27154220
[TBL] [Abstract][Full Text] [Related]
12. Comparison of the clinicopathologic features and prognosis of bilateral versus unilateral multifocal papillary thyroid cancer: An updated study with more than 2000 consecutive patients.
Wang W; Su X; He K; Wang Y; Wang H; Wang H; Zhao Y; Zhao W; Zarnegar R; Fahey TJ; Teng X; Teng L
Cancer; 2016 Jan; 122(2):198-206. PubMed ID: 26506214
[TBL] [Abstract][Full Text] [Related]
13. Tumor genotype determines phenotype and disease-related outcomes in thyroid cancer: a study of 1510 patients.
Yip L; Nikiforova MN; Yoo JY; McCoy KL; Stang MT; Armstrong MJ; Nicholson KJ; Ohori NP; Coyne C; Hodak SP; Ferris RL; LeBeau SO; Nikiforov YE; Carty SE
Ann Surg; 2015 Sep; 262(3):519-25; discussion 524-5. PubMed ID: 26258321
[TBL] [Abstract][Full Text] [Related]
14. High recurrent rate of multicentric papillary thyroid carcinoma.
Lin JD; Chao TC; Hsueh C; Kuo SF
Ann Surg Oncol; 2009 Sep; 16(9):2609-16. PubMed ID: 19533244
[TBL] [Abstract][Full Text] [Related]
15. Clinicopathologic Features of Fatal Non-Anaplastic Follicular Cell-Derived Thyroid Carcinomas.
Xu B; Ibrahimpasic T; Wang L; Sabra MM; Migliacci JC; Tuttle RM; Ganly I; Ghossein R
Thyroid; 2016 Nov; 26(11):1588-1597. PubMed ID: 27480016
[TBL] [Abstract][Full Text] [Related]
16. Low-risk differentiated thyroid cancer: the need for selective treatment.
Shaha AR; Shah JP; Loree TR
Ann Surg Oncol; 1997 Jun; 4(4):328-33. PubMed ID: 9181233
[TBL] [Abstract][Full Text] [Related]
17. Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer.
Mazzaferri EL; Jhiang SM
Am J Med; 1994 Nov; 97(5):418-28. PubMed ID: 7977430
[TBL] [Abstract][Full Text] [Related]
18. Pediatric Thyroid Microcarcinoma.
Lerner J; Goldfarb M
Ann Surg Oncol; 2015 Dec; 22(13):4187-92. PubMed ID: 25854844
[TBL] [Abstract][Full Text] [Related]
19. A National Cancer Data Base report on 53,856 cases of thyroid carcinoma treated in the U.S., 1985-1995 [see commetns].
Hundahl SA; Fleming ID; Fremgen AM; Menck HR
Cancer; 1998 Dec; 83(12):2638-48. PubMed ID: 9874472
[TBL] [Abstract][Full Text] [Related]
20. Multivariate analysis of the relationship between male sex, disease-specific survival, and features of tumor aggressiveness in thyroid cancer of follicular cell origin.
Nilubol N; Zhang L; Kebebew E
Thyroid; 2013 Jun; 23(6):695-702. PubMed ID: 23194434
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]